
Shirley V. Gembeh
Examiner (ID: 11999, Phone: (571)272-8504 , Office: P/1628 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1628, 1615, 1614, 1618 |
| Total Applications | 2053 |
| Issued Applications | 1120 |
| Pending Applications | 147 |
| Abandoned Applications | 807 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13409943
[patent_doc_number] => 20180256514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY
[patent_app_type] => utility
[patent_app_number] => 15/813571
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15813571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/813571 | METHODS FOR THE TREATMENT OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | Nov 14, 2017 | Abandoned |
Array
(
[id] => 18215341
[patent_doc_number] => 11590255
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Rubber-based soft gel skin adhesives
[patent_app_type] => utility
[patent_app_number] => 16/346655
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 26
[patent_no_of_words] => 9983
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346655 | Rubber-based soft gel skin adhesives | Nov 9, 2017 | Issued |
Array
(
[id] => 12231784
[patent_doc_number] => 20180064646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINE'
[patent_app_type] => utility
[patent_app_number] => 15/808694
[patent_app_country] => US
[patent_app_date] => 2017-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16797
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15808694
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/808694 | METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINE | Nov 8, 2017 | Abandoned |
Array
(
[id] => 18201133
[patent_doc_number] => 11583504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Stabilized formulations of lipid nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/348335
[patent_app_country] => US
[patent_app_date] => 2017-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 48
[patent_no_of_words] => 48390
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348335
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/348335 | Stabilized formulations of lipid nanoparticles | Nov 7, 2017 | Issued |
Array
(
[id] => 17814255
[patent_doc_number] => 11419842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Neutral pH compositions of Docetaxel and human serum albumin
[patent_app_type] => utility
[patent_app_number] => 16/345615
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 45916
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345615 | Neutral pH compositions of Docetaxel and human serum albumin | Oct 26, 2017 | Issued |
Array
(
[id] => 15975919
[patent_doc_number] => 10668261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Sheet-like piece, sheet for promoting hair growth comprising sheet-like piece, and whitening and wrinkle ameliorating agent comprising sheet-like piece
[patent_app_type] => utility
[patent_app_number] => 15/790335
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 41
[patent_no_of_words] => 12835
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/790335 | Sheet-like piece, sheet for promoting hair growth comprising sheet-like piece, and whitening and wrinkle ameliorating agent comprising sheet-like piece | Oct 22, 2017 | Issued |
Array
(
[id] => 12238523
[patent_doc_number] => 20180071386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION'
[patent_app_type] => utility
[patent_app_number] => 15/726665
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12291
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15726665
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/726665 | Silicon dioxide nanoparticles and the use thereof for vaccination | Oct 5, 2017 | Issued |
Array
(
[id] => 15491563
[patent_doc_number] => 20200045970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => PESTICIDAL MIXTURE
[patent_app_type] => utility
[patent_app_number] => 16/340545
[patent_app_country] => US
[patent_app_date] => 2017-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340545 | PESTICIDAL MIXTURE | Oct 3, 2017 | Abandoned |
Array
(
[id] => 14357725
[patent_doc_number] => 10300143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Compositions for treating cancer and methods for making the same
[patent_app_type] => utility
[patent_app_number] => 15/722831
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 93
[patent_no_of_words] => 38878
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/722831 | Compositions for treating cancer and methods for making the same | Oct 1, 2017 | Issued |
Array
(
[id] => 12259344
[patent_doc_number] => 20180078540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/719636
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16938
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15719636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/719636 | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor | Sep 28, 2017 | Issued |
Array
(
[id] => 17569970
[patent_doc_number] => 11318224
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-03
[patent_title] => Nanofiber structures and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/336276
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 38
[patent_no_of_words] => 7956
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336276 | Nanofiber structures and methods of use thereof | Sep 27, 2017 | Issued |
Array
(
[id] => 13968181
[patent_doc_number] => 10213423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Crenolanib for treating FLT3 mutated proliferative disorders
[patent_app_type] => utility
[patent_app_number] => 15/715274
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9505
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/715274 | Crenolanib for treating FLT3 mutated proliferative disorders | Sep 25, 2017 | Issued |
Array
(
[id] => 14578741
[patent_doc_number] => 20190216979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => MACROSCOPICALLY ALIGNABLE, INJECTABLE, SOFT HYDROGEL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/331454
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331454
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331454 | Macroscopically alignable, injectable, soft hydrogel composition | Sep 24, 2017 | Issued |
Array
(
[id] => 15738269
[patent_doc_number] => 20200108022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => ALBUMIN PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/321591
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321591 | Albumin pharmaceutical composition and preparation method therefor | Sep 20, 2017 | Issued |
Array
(
[id] => 12904261
[patent_doc_number] => 20180193262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON
[patent_app_type] => utility
[patent_app_number] => 15/708440
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15708440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/708440 | LIQUID PHARMACEUTICAL FORMULATIONS OF PALONOSETRON | Sep 18, 2017 | Abandoned |
Array
(
[id] => 14261255
[patent_doc_number] => 10280179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
[patent_app_type] => utility
[patent_app_number] => 15/707729
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 66825
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1822
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707729
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/707729 | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death | Sep 17, 2017 | Issued |
Array
(
[id] => 16563192
[patent_doc_number] => 10888539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Methods of treating or preventing prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/703782
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17358
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703782 | Methods of treating or preventing prostate cancer | Sep 12, 2017 | Issued |
Array
(
[id] => 13127397
[patent_doc_number] => 10081619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Biaryl inhibitors of bruton's tyrosine kinase
[patent_app_type] => utility
[patent_app_number] => 15/699857
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79581
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699857
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/699857 | Biaryl inhibitors of bruton's tyrosine kinase | Sep 7, 2017 | Issued |
Array
(
[id] => 17306251
[patent_doc_number] => 11207333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
[patent_app_type] => utility
[patent_app_number] => 16/330486
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 32966
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330486 | Compositions comprising triterpenoids and uses thereof for treating optic neuropathy | Sep 6, 2017 | Issued |
Array
(
[id] => 17176830
[patent_doc_number] => 11154057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Use of nootkatone to treat mosquito infestations
[patent_app_type] => utility
[patent_app_number] => 16/328885
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 13601
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16328885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/328885 | Use of nootkatone to treat mosquito infestations | Aug 31, 2017 | Issued |